Laquinimod in Participants With Systemic Lupus Erythematosus Active Lupus Nephritis
- Study Title
- Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
- Teva Identifier
- LN-LAQ-201 | 2010-018329-20
- ClinicalTrials.gov Identifier
- NCT01085097
- Study Status
- Completed
- Trial Condition(s)
- Lupus Nephritis
- Interventions
- Drug: laquinimod | Drug: Mycophenolate Mofetil | Drug: prednisolone/prednisone | Drug: Placebo
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 18 Years to 75 Years
- Trial Duration
- 07/01/2010 - 12/01/2012
- Phase
- Phase 2
